Faruqi and Faruqui, LLP Logo
Share this page

Vascular Solutions, Inc. (VASC)

NasdaqGS:VASC

Summary

Faruqi & Faruqi, LLP Announces the Investigation of Vascular Solutions, Inc. (VASC) Over the Proposed Sale of the Company to Teleflex Incorporated

Nadeem Faruqi, founding partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Vascular Solutions, Inc. (“Vascular” or the “Company”) (NasdaqGS:VASC) for potential breaches of fiduciary duties in connection with the sale of the Company to Teleflex Incorporated for approximately $1 billion.

The Company’s stockholders will only receive $56.00 in cash for each share of Vascular common stock they own. However, the offer is below the 52-week high price of $57.15 per share and a price target of $58.00 per share set by Needham & Company in October

If you own common stock in Vascular and wish to obtain additional information and protect your investments free of charge, please fill out the form below at www.faruqilaw.com/VASC or contact Nadeem Faruqi, Esq. either via e-mail at nfaruqi@faruqilaw.com or by telephone at (877) 247-4292 or (212) 983-9330.  You may also contact Juan E. Monteverde, Esq.  either via email at jmonteverde@monteverdelaw.com or by telephone at (212) 971-1341.

Request Information

Please tell us about yourself by completing the form below and we will provide you with additional
information at no cost to you on how to join the Class Action.

  • Company:
    Vascular Solutions, Inc. (VASC)
  •    

* The submission of this form does not create an attorney-client relationship.

Contact Counsel

Nadeem Faruqi
Faruqi & Faruqi, LLP
685 Third Avenue 26th Floor
New York, NY 10017
Tel: (212) 983-9330

Email:

Case Details

Date:

  • 12/09/2016

Send Information

If you have information regarding this case that you would like to make available, please click here to contact us about our investigation.